Reiter's syndrome following intravesical BCG immunotherapy.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11085772.
- Also identified by PMC identifier 1741835.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 71 year old woman developed conjunctivitis, asymmetrical oligoarthritis, and cystitis (Reiter's syndrome) secondary to intravesical BCG treatment for transitional cell carcinoma of the bladder. She received oral prednisolone, izoniazid, and pyridoxine and made a full recovery. Increasing use of BCG as immunotherapy will lead to an increase in the incidence of BCG associated reactive arthritis. Prompt recognition and early diagnosis will facilitate treatment and recovery.
Medical subject headings
- Arthritis, Reactive
- BCG Vaccine